ImmunityBio IBRX
NASDAQ IBRX
$8.11 -0.08 (-0.98%)
As of: Sep 4, 2026 · 3:20 PM EDT

ImmunityBio (IBRX) Tax Rate (QoQ) (2016 - 2026)

Analysis

ImmunityBio (IBRX) Tax Rate (QoQ) (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 ImmunityBio 8.45 Bn 8.09 Bn 50.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -22.00
Dec 31, 2025 17.00
Sep 30, 2025 38.00
Jun 30, 2025 -51.00
Jun 30, 2021 1.00
Mar 31, 2021 -31.00
Dec 31, 2020 -220.00
Sep 30, 2020 259.00
Jun 30, 2020 -4.00
Mar 31, 2020 -11.00
Jun 30, 2019 -21.00
Mar 31, 2019 -53.00
Dec 31, 2018 19.00
Sep 30, 2018 10.00
Jun 30, 2018 -1.00
Mar 31, 2018 -25.00
Dec 31, 2017 29.00
Sep 30, 2017 -11.00
Jun 30, 2017 13.00
Mar 31, 2017 -21.00